Archive \ Volume.14 2023 Issue 2

Computer-Assisted Evaluation of Patient Information Leaflets (PILs) for Chronic Kidney Disease Compared with Marketed PILs

Ruhul Amin, Faruk Alam, Biplab Kumar Dey

Printed educational materials play an important part in the treatment of disease. The patient may use them as a reference at home or to enhance knowledge. The goal of this study was to use standard approaches, such as Baker Able Leaflet Design (BALD) and readability score, to the evaluation of patients' opinions on Patient Information Leaflets (PILs) for chronic kidney disease. Participate were enrolled randomly, and some were taken at a convenient time. The study spanned 1 year in a hospital in Assam, India. We compiled our Patient Information Leaflets (PILs) by referring to various sources of information and translating them into the Assamese language. With the help of the BALD assessment strategy and user rating, we compared our PILs with available PILs on the website and marketed them. The prepared leaflets scored "above standard" in BALD and readability evaluations, indicating that they are above the industry standard. since their average score was greater than 25, the layout and design. This shows that the issue is important from the patient's perspective, which may encourage them to read the PILs. Even though a larger percentage of Indian consumers cannot read or write English, many PILs are still written in the English language. Without considering the patient's reading levels and ensuring proper style and design, PILs may not be understood or used. Every company has to take this into account when creating leaflets and, at the absolute least, in some of the most important local languages in which PILs must be published.

Downloads: 32
Views: 47

How to cite:
Amin R, Alam F, Dey BK. Computer-Assisted Evaluation of Patient Information Leaflets (PILs) for Chronic Kidney Disease Compared with Marketed PILs. Arch Pharm Pract. 2023;14(2):25-9.
Amin, R., Alam, F., & Dey, B. K. (2023). Computer-Assisted Evaluation of Patient Information Leaflets (PILs) for Chronic Kidney Disease Compared with Marketed PILs. Archives of Pharmacy Practice, 14(2), 25-29.

Download Citation

1.        Amin R, Dey BK, Abdulsalim S, Manu MK. Preparation and Validation of User-based Patients Information Leaflets (PILs) for COPD Patients in Indian Regional Languages: A Prospective Observational Study. Int J Pharm Investig. 2022. doi:10.5530/ijpi.2021.2.43

2.        Ladin K, Tighiouart H, Bronzi O, Koch-Weser S, Wong JB, Levine S, et al. Effectiveness of an Intervention to Improve Decision Making for Older Patients with Advanced Chronic Kidney Disease: A Randomized Controlled Trial. Ann Intern Med. 2023;176(1):29-38.

3.        Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157-72. doi:10.1161/CIRCULATIONAHA.120.05068

4.        Mahalingasivam V, Su G, Iwagami M, Davids MR, Wetmore JB, Nitsch D. COVID-19 and kidney disease: insights from epidemiology to inform clinical practice. Nat Rev Nephrol. 2022;18(8):485-98. doi:10.1038/s41581-022-00570-3

5.        Jdiaa SS, Mansour R, El Alayli A, Gautam A, Thomas P, Mustafa RA. COVID–19 and chronic kidney disease: an updated overview of reviews. J Nephrol. 2022:1-7. doi:10.1007/s40620-021-01206-8

6.        Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3(1):19-62. doi:10.1038/kisup.2012.64

7.        Srivastava RN. Nephrotic syndrome: Indian society of pediatric nephrology management guidelines. Asian J Pediatr Nephrol. 2021;4(2):45.

8.        Mateti UV, Nagappa AN, Attur RP, Nagaraju SP, Rangaswamy D. Impact of pharmaceutical care on clinical outcomes among hemodialysis patients: A multicenter randomized controlled study. Saudi J Kidney Dis Transplant. 2018;29(4):801-8.

9.        Rahman RK, Mattilda A, Iyengar A. Assessment of Dietary Phosphorus Intake and Implementation of Parental Phosphate Education in Pediatric Chronic Kidney Disease. Indian J Nephrol. 2023:1-7.

10.      Amin R, Alam F, Dey BK. The Evaluation and Effectiveness of Regional Language Patient Information Leaflets for Persons with Chronic Kidney Disease. Int J Pharm Investig. 2023. doi:10.5530/ijpi.13.2.046

11.      Measure your readability. Available from:

12.      Baker SJ. Who can read consumer product information?. Aust J Hosp Pharm. 1997;27(2):126-31.

13.      Mcinnes N, Haglund BJ. Readability of online health information: implications for health literacy. Inform Health Soc Care. 2011;36(4):173-89.

14.      Jones J, Rosaasen N, Taylor J, Mainra R, Shoker A, Blackburn D, et al. Health literacy, knowledge, and patient satisfaction before kidney transplantation. InTransplantation Proceedings 2016 Oct 1 (Vol. 48, No. 8, pp. 2608-2614). Elsevier.

15.      Hwang SJ, Tan NC, Yoon S, Ramakrishnan C, Paulpandi M, Gun S, et al. Perceived barriers and facilitators to chronic kidney disease care among patients in Singapore: a qualitative study. BMJ Open. 2020;10(10):e041788.

16.      Larsen MH, Mengshoel AM, Andersen MH, Borge CR, Ahlsen B, Dahl KG, et al. “A bit of everything”: Health literacy interventions in chronic conditions–a systematic review. Patient Educ Couns. 2022.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.